报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | -0.23% | -276.92% | 86.71% | 114/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
2024-12-31 | -1.73% | -111.09% | -917.65% | 106/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
2024-09-30 | -0.17% | -100.83% | 66% | 114/159 | 4.18% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | -0.5% | -102.52% | -484.62% | 118/159 | 2.63% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | 0.13% | -99.35% | -99.17% | 114/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | 15.6% | -30.39% | -23.94% | 9/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | 20.51% | 114.76% | 3.22% | 1/159 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | 19.87% | 365.34% | -0.2% | 1/159 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | 19.91% | 677.73% | -11.16% | 1/159 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | 22.41% | 119.71% | 134.66% | 4/159 | 0.74% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | 9.55% | -21.53% | 123.65% | 33/159 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | 4.27% | -57.34% | 66.8% | 58/159 | 2.22% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | 2.56% | 2% | -74.9% | 51/159 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | 10.2% | -57.83% | -16.19% | 42/159 | 0.87% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | 12.17% | 2% | 21.58% | 20/159 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | 10.01% | -18.42% | -58.62% | 16/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2020-12-31 | 24.19% | 42.8% | 97.15% | 13/159 | 3.71% | 汇宇制药 | 28.14% | 行业排名> |
2020-06-30 | 12.27% | 43.68% | -27.57% | 12/159 | 4.24% | 哈三联 | 27.17% | 行业排名> |
2019-12-31 | 16.94% | -21.94% | -21.94% | 29/159 | 2.71% | 汇宇制药 | 55.94% | 行业排名> |
2018-12-31 | 21.7% | 68.48% | 154.1% | 12/159 | 7.09% | 河化股份 | 45.32% | 行业排名> |
2018-06-30 | 8.54% | 86.06% | -33.7% | 15/159 | 4.65% | 汇宇制药 | 31.9% | 行业排名> |
2017-12-31 | 12.88% | 898.45% | 180.61% | 32/159 | 9.66% | 誉衡药业 | 35.56% | 行业排名> |
2017-06-30 | 4.59% | 2% | 255.81% | 50/159 | 5.59% | 奥赛康 | 35% | 行业排名> |
2016-12-31 | 1.29% | 2% | 2% | 98/159 | 6.33% | 奥赛康 | 28.15% | 行业排名> |